| 1 | Avonex (interferon beta-1a), Biogen Idec Ltd (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 2 | Avonex/Betaseron/Copaxone/Rebif | [3]  Glatiramer Glatiramer, Interferon beta-1a (Rebif Rebidose), Interferon beta-1b | [2]  Interferon beta-1b 
                
                    Interferon beta-1b
                
            , 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 3 | BG9418 (interferon beta-1a) (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2]  13 13, 97 💬
 | 
| 4 | Human interferon beta 1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 5 | Human interferon beta-1a and glatiramer acetate (Rebif) | [4]  Acetate Acetate, Glatiramer, Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 6 | IFN-beta-1a (Rebif®) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 7 | IFN-ß-1a (Rebif®) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 8 | INTERFERON BETA-1A (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [4]  13 13, 26, 96, 97 💬
 | 
| 9 | Interferon beta-1a (Avonex) (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 10 | INTERFERON BETA-1A (Avonex®) (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 11 | Interferon beta-1a (current approved manufacturing process invloving FBS) (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 12 | Interferon beta-1a (new process, manufactured without FBS) (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 13 | Interferon beta-1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 14 | Interferon beta-1a (Rebif®) alone | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 15 | Interferon beta-1a 30 µg (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 16 | Interferon beta-1a FBS-free/HSA free, RNF (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 17 | Interferon beta-1a FBS-free/HSA-free (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 18 | Interferon beta-1a FBS-free/HSA-free, RNF (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 19 | Interferon beta-1a HSA+ biosimilar (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 20 | Interferon beta-1a HSA-free biosimilar (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 21 | Interferon beta-1a original (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 22 | Interferon Beta-1A Prefilled Syringe (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 23 | Interferon beta-1a, 30 µg/0.5 ml (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 24 | New Formulation of rebif - human interferon beta-1a | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 25 | PEGylated Interferon Beta-1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 26 | REBIF | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 27 | Rebif (IFN beta-1a subcutaneous three times per week) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 28 | Rebif (IFN ß-1a subcutaneous three times per week) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 29 | Rebif (interferon beta 1a) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 30 | Rebif (Interferon beta-1a) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 31 | Rebif (interferon beta-1a), Merck Serono Europe Ltd | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 32 | REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 33 | Rebif 22 | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 34 | Rebif 22 micrograms | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 35 | Rebif 22 y 44 mcg | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 36 | Rebif 22® | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 37 | Rebif 44 | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 38 | Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 39 | REBIF 44 microgramos solución inyectable | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 40 | REBIF 44 microgramos solución inyectable en jeringa precargada | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 41 | Rebif 44 micrograms | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 42 | Rebif 44 micrograms solution for injection | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 43 | Rebif 44 micrograms solution for injection in pre-filled syringe | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 44 | Rebif 44 µg | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 45 | Rebif 44® | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 46 | Rebif 8,8 µg, Rebif 22µg | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 47 | Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 48 | Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack. | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 49 | Rebif New Formulation + ibuprofen PRN | [1]  Ibuprofen Ibuprofen | [1]  Ibuprofen 
                
                    Ibuprofen
                
             💬
 | [2]  PTGS1 PTGS1, PTGS2 💬
 | [23]  Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1]  13 13 💬
 | 
| 50 | Rebif New Formulation + prophylactic Ibuprofen | [1]  Ibuprofen Ibuprofen | [1]  Ibuprofen 
                
                    Ibuprofen
                
             💬
 | [2]  PTGS1 PTGS1, PTGS2 💬
 | [23]  Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1]  13 13 💬
 | 
| 51 | Rebif New Formulation 44mcg multidose cartridge | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 52 | Rebif New Formulation Non Titrated | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 53 | Rebif New Formulation Titrated | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 54 | REBIF SC 12SIR 12000000UI44MCG | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 55 | REBIF SC 12SIR 6000000UI 22MCG | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 56 | REBIF*SC 12SIR 12000000UI44MCG | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 57 | REBIF*SC 12SIR 6000000UI 22MCG | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 58 | Rebif® | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 59 | Rebif® (clone 484-39) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 60 | Rebif® New Formulation | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 61 | Rebif® New Formulation (IFN-beta-1a, RNF) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 62 | Rebif® new formulation (RNF) | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 63 | Rebif® New Formulation (RNF) using RebiSmartTM | [1]  Interferon beta-1a Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 64 | Recombinant human interferon beta-1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  26 26 💬
 | 
| 65 | SC interferon beta-1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 66 | VigantOL oil plus interferon beta-1a (Rebif) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a (Rebif Rebidose) | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             (Rebif) 💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 |